Pricing Log in Create free account

Beta Bionics, Inc. (BBNX) vs InMode Ltd. (INMD)

Beta Bionics, Inc. and InMode Ltd. are both Medical Devices companies. Beta Bionics, Inc. is the larger, with a market value of $933.8M against $824.0M — 1.1× the size. Beta Bionics, Inc. has negative trailing earnings, so its P/E is not meaningful; InMode Ltd. trades at 11.3×. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against −6.71%. InMode Ltd. has the higher net margin (20.7% vs −61.3%) and the higher return on invested capital (33.8% vs −68.5%). Across the 16 metrics below, InMode Ltd. leads on 13 and Beta Bionics, Inc. on 3.

Valuation

Metric BBNX INMD Medical Devices median
P/E n/m 11.33 23.22
P/S 6.12 2.23 2.34
P/B 2.84 1.22 2.33
Price to free cash flow n/m 10.11 23.72
EV/EBITDA n/m 4.76 11.54
EV/Sales 4.60 0.89 2.24
Earnings yield (10.09%) 8.83% (10.09%)
Free cash flow yield (46.43%) 9.89% (8.47%)

Profitability

Metric BBNX INMD Medical Devices median
Gross margin 58.31% 76.52% 56.01%
Operating margin (69.75%) 18.47% (15.03%)
Net margin (61.32%) 20.69% (20.40%)
Free cash flow margin (284.13%) 22.03% (7.24%)
Return on equity (26.16%) 0.00% (15.32%)
Return on assets (23.45%) 10.85% (19.72%)
Return on invested capital (68.47%) 33.78% (10.33%)

Growth

Metric BBNX INMD Medical Devices median
Revenue growth (TTM) 52.54% (6.71%) 8.80%
EPS growth (last fiscal year) 78.95% (36.44%) 29.03%
Revenue growth, 5-year CAGR — 12.44% 15.47%
Net income growth, 5-year CAGR — 4.57% 0.00%

Health

Metric BBNX INMD Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 8.88 8.18 2.50
Net debt to EBITDA 3.19 (6.45) 0.49

Dividend

Metric BBNX INMD Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BBNX INMD Medical Devices median
Market cap 933.81m 824.03m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack